FIELD: medicine.
SUBSTANCE: offered is a method and a set of primers for determining a haplotype of a DNA-target containing two heterozygous polymorphic sites. The method according to the invention provides a) taking a genome DNA sample and amplifying the area on the 3'-side of which there is a first polymorphic site, and on the 5'-side of which the second polymorphic site is found; b) conducting a PCR of said specific area with using one of two primers allele-specific relatively to the first polymorphic site and a downstream primer which is located so that to include the second polymorphic site in an amplicon; c) hybridising the prepared PCR product with two probes one of which is specific to a mutant type sequence, and another one - to a wild type sequence within the second polymorphism and d) determining a haplotype where the first polymorphism is described by a type of an extended upstream primer, and the second polymorphism - by a type of the probe hybridised with the PCR product.
EFFECT: use of the invention provides relatively simple and high precise diagnostic system.
4 cl, 5 dwg, 5 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ANALYSIS OF GENETIC POLYMORPHYSM, DEFINING PREDISPOSITION TO TUMOR DISEASES AND INDIVIDUAL SENSITIVITY TO PHARMACEUTICAL AGENTS BY USING OLYGONUCLEOTIDE BIOLOGICAL MICROARRAY (BIOARRAY) | 2005 |
|
RU2303634C2 |
DETECTION OF MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | 2015 |
|
RU2717641C2 |
HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS | 2012 |
|
RU2650790C2 |
METHOD FOR PREDICTION OF POPULATION BIOTRANSFORMATION DISORDERS OF FOREIGN SUBSTANCES CAUSED BY EXPOSURE TO MAN-INDUCED CHEMICAL HABITAT FACTORS | 2012 |
|
RU2497120C1 |
METHODS OF DETECTING AND MONITORING CANCER BY PERSONALIZED DETECTION OF CIRCULATING TUMOR DNA | 2019 |
|
RU2811503C2 |
METHOD FOR IDENTIFICATION OF GENETIC POLYMORPHISMS AFFECTING METABOLISM OF ANTICANCER DRUGS USING BIOLOGICAL MICROCHIPS | 2018 |
|
RU2697096C1 |
METHOD OF ANALYZING POLYMORPHIC MARKERS IN THE GENES VKORC1, CYP4F2, CYP2C9, CYP2C19, ABCB1, ITGB3 TO DETERMINE INDIVIDUAL SENSITIVITY TO ANTICOAGULANT DRUGS | 2018 |
|
RU2689400C1 |
MULTI-ALLELIC GENOTYPING OF SINGLE NUCLEOTIDE POLYMORPHISMS AND INDEL MUTATIONS | 2016 |
|
RU2706203C1 |
GENETIC MARKERS FOR PREDICTING RESPONSE TO THERAPY BY RAISING HDL LEVEL OR IMITATING HDL AGENTS | 2015 |
|
RU2703192C2 |
GENETIC MARKERS FOR PREDICTING SENSITIVITY TO THERAPY | 2014 |
|
RU2809215C2 |
Authors
Dates
2011-04-20—Published
2007-11-30—Filed